Cost analysis of treating cardiovascular diseases in a super-specialty hospital
Open Access
- 5 January 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (1) , e0262190
Abstract
Cardiovascular care is expensive; hence, economic evaluation is required to estimate resources being consumed and to ensure their optimal utilization. There is dearth of data regarding cost analysis of treating various diseases including cardiac diseases from developing countries. The study aimed to analyze resource consumption in treating cardio-vascular disease patients in a super-specialty hospital. An observational and descriptive study was carried out from April 2017 to June 2018 in the Department of Cardiology, Cardio-Thoracic (CT) Centre of All India Institute of Medical Sciences, New Delhi, India. As per World Health Organization, common cardiovascular diseases i.e. Coronary Artery Disease (CAD), Rheumatic Heart Disease (RHD), Cardiomyopathy, Congenital heart diseases, Cardiac Arrhythmias etc. were considered for cost analysis. Medical records of 100 admitted patients (Ward & Cardiac Care Unit) of cardiovascular diseases were studied till discharge and number of patient records for a particular CVD was identified using prevalence-based ratio of admitted CVD patient data. Traditional Costing and Time Driven Activity Based Costing (TDABC) methods were used for cost computation. Per bed per day cost incurred by the hospital for admitted patients in Cardiac Care Unit, adult and pediatric cardiology ward was calculated to be Indian Rupee (INR) 28,144 (US$ 434), INR 22,210 (US$ 342) and INR 18,774 (US$ 289), respectively. Inpatient cost constituted almost 70% of the total cost and equipment cost accounted for more than 50% of the inpatient cost followed by human resource cost (28%). Per patient cost of treating any CVD was computed to be INR 2,47,822 (US $ 3842). Cost of treating Rheumatic Heart Disease was the highest among all CVDs followed by Cardiomyopathy and other CVDs. Cost of treating cardiovascular diseases in India is less than what has been reported in developed countries. Findings of this study would aid policy makers considering recent radical changes and massive policy reforms ushered in by the Government of India in healthcare delivery.Keywords
All Related Versions
This publication has 19 references indexed in Scilit:
- Direct Medical Costs of Hospitalizations for Cardiovascular Diseases in Shanghai, ChinaMedicine, 2015
- Determinants of the direct cost of heart failure hospitalization in a public tertiary hospitalInternational Journal of Cardiology, 2015
- The financial burden from non-communicable diseases in low- and middle-income countries: a literature reviewHealth Research Policy and Systems, 2013
- Cost Analysis of Operation Theatre Services at an Apex Tertiary Care Trauma Centre of IndiaIndian Journal of Surgery, 2013
- Cardiovascular Disease in the Developing WorldJACC, 2012
- Cannula-Based 25-Gauge Vitreous Tap And InjectionRetina, 2012
- A Cross-Sectional Study of the Microeconomic Impact of Cardiovascular Disease Hospitalization in Four Low- and Middle-Income CountriesPLOS ONE, 2011
- Medical care costs among patients with established cardiovascular disease.2010
- The Impact of Cardiovascular Disease on Medical Care Costs in Subjects With and Without Type 2 DiabetesDiabetes Care, 2002
- A new method of accurately identifying costs of individual patients in intensive care: the initial results.Intensive Care Medicine, 1997